Antiganglioside GM1 Antibodies and Their Complement Activating Capacity in Central and Peripheral Nervous System Disorders and in Controls

Publisher： Karger

E-ISSN： 1421-9913|39|2|103-110

ISSN： 0014-3022

Source： European Neurology, Vol.39, Iss.2, 1998-02, pp. : 103-110

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Complement System in SLE as a Target for Antibodies

By  

Current Rheumatology Reviews, Vol. 9, Iss. 1, 2013-02 ,pp. : 34-44

Bentham Science Publishers

Access to resources Recommend Favorite

Central Nervous System Plus Autonomic Nervous System Disorders Responsible for Gastrointestinal and Pancreatobiliary Diseases

By Lechin Fuad   Dijs Bertha  

Digestive Diseases and Sciences, Vol. 54, Iss. 3, 2009-03 ,pp. : 458-470

Springer Publishing Company

Access to resources Recommend Favorite

Regeneration in the central nervous system

By Bandtlow C.E.  

Experimental Gerontology, Vol. 38, Iss. 1, 2003-01 ,pp. : 79-86

Elsevier

Access to resources Recommend Favorite

HIV-1 gp120 and Drugs of Abuse: Interactions in the Central Nervous System

By  

Current HIV Research, Vol. 10, Iss. 5, 2012-07 ,pp. : 369-383

Bentham Science Publishers

Access to resources Recommend Favorite

Central Nervous System Effects of Leptin

By Buchanan C.   Mahesh V.   Zamorano P.   Brann D.  

Trends in Endocrinology and Metabolism, Vol. 9, Iss. 4, 1998-12 ,pp. : 146-150

Elsevier

Access to resources Recommend Favorite